• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 4. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 5. Exclusive enantioselective recognition of glucopyranosides by inherently chiral hemicryptophanes?
  Olivier Perraud,Alexandre Martinez,Jean-Pierre Dutasta Chem. Commun., 2011,47, 5861-5863

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzoxazoles Benzoxazolones

Recent Advances in the Study of 5-Methoxy-3H-1,3-benzoxazol-2-one (CAS: 40925-63-1): A Comprehensive Research Brief

The compound 5-methoxy-3H-1,3-benzoxazol-2-one (CAS: 40925-63-1) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to synthesize the latest findings related to this compound, focusing on its synthesis, biological activities, and potential clinical applications. The insights provided here are based on peer-reviewed studies published within the last five years, ensuring the relevance and accuracy of the information presented.

Recent studies have highlighted the versatility of 5-methoxy-3H-1,3-benzoxazol-2-one as a scaffold in medicinal chemistry. Its benzoxazolone core is known to interact with various biological targets, including enzymes and receptors, making it a promising candidate for drug development. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy as an inhibitor of monoamine oxidase (MAO), suggesting potential applications in neurodegenerative diseases such as Parkinson's and Alzheimer's. The study utilized advanced computational modeling and in vitro assays to validate its binding affinity and selectivity.

In addition to its neurological applications, 5-methoxy-3H-1,3-benzoxazol-2-one has shown promise in oncology research. A 2022 paper in Bioorganic & Medicinal Chemistry Letters reported its role in inducing apoptosis in certain cancer cell lines, particularly those resistant to conventional chemotherapy. The mechanism of action appears to involve the modulation of reactive oxygen species (ROS) and the activation of intrinsic apoptotic pathways. These findings open new avenues for the development of targeted cancer therapies.

The synthesis and optimization of 5-methoxy-3H-1,3-benzoxazol-2-one derivatives have also been a focal point of recent research. A 2021 study in Organic & Biomolecular Chemistry detailed a novel, high-yield synthetic route that improves the scalability and purity of the compound. This advancement is critical for facilitating further preclinical and clinical studies. Moreover, structural-activity relationship (SAR) studies have identified key modifications that enhance its pharmacokinetic properties, such as bioavailability and metabolic stability.

Despite these promising developments, challenges remain in the translation of 5-methoxy-3H-1,3-benzoxazol-2-one into clinical practice. Issues such as off-target effects, toxicity profiles, and formulation stability need to be addressed through rigorous preclinical testing. Collaborative efforts between academic researchers and pharmaceutical companies are essential to overcome these hurdles and accelerate the compound's journey from bench to bedside.

In conclusion, 5-methoxy-3H-1,3-benzoxazol-2-one (CAS: 40925-63-1) represents a compelling area of research with multifaceted therapeutic potential. Its applications in neurology and oncology, coupled with advancements in synthetic chemistry, underscore its value as a lead compound. Future studies should focus on elucidating its mechanisms of action in greater detail and optimizing its drug-like properties to maximize clinical utility. This research brief serves as a timely update for professionals in the field, providing a foundation for further exploration and innovation.

• 532-91-2(Coixol)
• 20129-18-4(2(3H)-Benzoxazolone, zinc salt (2:1))
• 42142-71-2(2(3H)-Benzoxazolone, sodium salt (1:1))
• 54113-76-7(Carbamic acid, (2-methoxyphenyl)-, phenyl ester)
• 59-49-4(2-Benzoxazolinone)
• 22876-17-1(6-amino-3H-1,3-benzoxazol-2-one)
• 81900-93-8(4-amino-3H-1,3-benzoxazol-2-one)
• 14733-77-8(5-amino-2,3-dihydro-1,3-benzoxazol-2-one)
• 28955-70-6(1,3-benzoxazole-2,4-diol)
• 78213-03-3(6-Hydroxy-2-benzoxazolinone)